JPH09196909A - Preservation of collected urine and urine collecting kit - Google Patents

Preservation of collected urine and urine collecting kit

Info

Publication number
JPH09196909A
JPH09196909A JP8030013A JP3001396A JPH09196909A JP H09196909 A JPH09196909 A JP H09196909A JP 8030013 A JP8030013 A JP 8030013A JP 3001396 A JP3001396 A JP 3001396A JP H09196909 A JPH09196909 A JP H09196909A
Authority
JP
Japan
Prior art keywords
urine
collected
test tube
holder
collection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP8030013A
Other languages
Japanese (ja)
Other versions
JP3592822B2 (en
Inventor
Shoji Okuda
尚司 奥田
Noboru Miyaji
登 宮地
Kazuo Uchida
壱夫 内田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
IKAGAKU KK
Original Assignee
IKAGAKU KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IKAGAKU KK filed Critical IKAGAKU KK
Priority to JP03001396A priority Critical patent/JP3592822B2/en
Publication of JPH09196909A publication Critical patent/JPH09196909A/en
Application granted granted Critical
Publication of JP3592822B2 publication Critical patent/JP3592822B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)
  • Sampling And Sample Adjustment (AREA)
  • Anti-Oxidant Or Stabilizer Compositions (AREA)

Abstract

PROBLEM TO BE SOLVED: To preserve or transfer collected urine while preventing the denaturalization or increase and decrease of dissolved components in urine by adding a acid of every kind to collected urine to adjust the pH of urine to a specified value range and adding an antibacterial agent, a fluorine compd. and an oxidation inhibitor to collected urine. SOLUTION: The urine collecting kit consists of an almost cylindrical urine collecting holder 1, the test tube 2 inserted into the holder 1 at a time of the collection of urine and a bottomed cylindrical urine collecting cup 3 and a urine collecting jig 4 is attached to the leading end part 21a of the holder 1. The test tube 2 is hermetically sealed by a cap 2a composed of an elastic material and internally held to a predetermined depressurized state. Further, an indication band 2b is provided to the proper place of the test tube 2. The test tube 2 is preliminarily packed with a pH adjusting acid, an antibacterial agent, a fluorine compd. and an oxidation inhibitor. As the pH adjusting acid, for example, granular citric acid is used and the pH of collected urine is adjusted to 4.5-6.5.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【発明の属する技術分野】本発明は、尿中溶存成分の変
性や増減を防止しつつ採取尿を移送できる採取尿の保存
方法に関し、また、この保存方法を実現するのに好適な
採尿用キットに関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a method for preserving collected urine capable of transferring collected urine while preventing denaturation and increase / decrease of dissolved components in urine, and a urine collecting kit suitable for realizing this method of preservation. Regarding

【0002】[0002]

【従来の技術】一般的に1日に数回ある排尿行為のう
ち、ある1回の排尿時に、その一部分の尿(部分尿)を
採取して、種々の検査にあてることが多い。この部分尿
を対象にした各種測定項目の定量値には、排尿の時々で
尿の濃い/薄いがあるなど尿量誤差が大きいことから、
種々の補正が行われている。代表的には、クレアチニン
を測定対象にしており、検査目的で採取された部分尿に
ついて、目的とする成分とクレアチニンとを測定し、ク
レアチニン1g当たりに換算して目的成分濃度を求めて
いる。
2. Description of the Related Art Generally, among urination actions that occur several times a day, a part of urine (partial urine) is often collected during a certain urination period and subjected to various tests. Since quantitative values of various measurement items for this partial urine have large urine volume errors, such as urine concentration / thinness depending on the time of urination,
Various corrections have been made. Typically, creatinine is the measurement target, and the target component and creatinine are measured in the partial urine collected for the purpose of the test, and the target component concentration is calculated by converting it to 1 g of creatinine.

【0003】[0003]

【発明が解決しようとする課題】しかしながら、特に、
目的成分を集団検診として測定するような場合には、ク
レアチニンを測定対象にした補正が正しく機能しない場
合があった。また、従来は、所定量の部分尿を確実に採
取できるとともに、尿中溶存成分の変性や増減を防止し
つつ採取尿を移送できる適当な採尿用キットも存在しな
かった。本発明は、これらの実情に鑑みたものであっ
て、尿中溶存成分の変性や増減を防止しつつ採取尿を保
存または移送できると共に、クレアチニンを測定対象に
して目的成分濃度を正確に検出できる方法を提供するこ
とを目的とする。また、この方法を実現するのに好適で
あり、所定量の部分尿を簡易かつ確実に採取できる採尿
用キットを提供することを目的とする。
However, in particular,
In the case of measuring the target component as a mass screening, the correction using creatinine as a measurement target may not function properly. Further, conventionally, there has been no suitable urine collecting kit that can reliably collect a predetermined amount of partial urine and that can transfer the collected urine while preventing denaturation or increase / decrease of dissolved components in urine. The present invention has been made in view of these circumstances, and it is possible to store or transfer the collected urine while preventing the denaturation or increase / decrease of dissolved components in urine, and to accurately detect the concentration of the target component by measuring creatinine. The purpose is to provide a method. Another object of the present invention is to provide a urine collection kit that is suitable for realizing this method and that can collect a predetermined amount of partial urine easily and reliably.

【0004】[0004]

【課題を解決するための手段】上記の目的を達成するた
め、種々の検討をした結果、採取尿が37℃以上の高温
で長時間放置されると、尿中の常在成分が酸化反応を起
こし、クレアチニンが酸化されてクレアトールもしくは
メチルグアニジンに変化するため、クレアチニン値が低
下するという事実を確認した。例えば、目的成分が集団
検診として測定されるような場合には採取尿が郵送され
ることもあり、高温期には郵便ポスト内の温度が50℃
〜70℃に達することもあるので、採取尿が37℃以上
の高温で長時間放置されることは十分に起こりえる。そ
こで、本発明では、かかる事態に対処すべく、pH調整
用の酸と、抗菌性薬剤と、フッ素化合物と、抗酸化剤と
を採取尿に添加することにした。採取尿に各種酸を加え
てpHを4.5〜6.5に調整すると共に、抗菌性薬剤
と所定量のフッ素化合物とを添加して採取尿を保存する
と、C−ペプチド、アルブミン、グリシン、尿素、ぶど
う糖などの尿中溶存成分の変性や増減を防止することが
できる(特願平5−5675号参照)。また、本発明で
は、採取尿に抗酸化剤を更に添加するので、クレアチニ
ンを測定対象にして目的成分濃度を正確に検出すること
もできる。
[Means for Solving the Problems] In order to achieve the above object, as a result of various investigations, when the collected urine is left at a high temperature of 37 ° C. or higher for a long time, the resident component in the urine undergoes an oxidation reaction. It was confirmed that the creatinine level decreased due to the oxidization of creatinine into creatol or methylguanidine. For example, when the target component is measured as a mass examination, the collected urine may be mailed, and the temperature inside the post may be 50 ° C during the high temperature period.
Since the temperature may reach to 70 ° C, it is sufficiently possible that the collected urine is left at a high temperature of 37 ° C or higher for a long time. Therefore, in the present invention, in order to cope with such a situation, an acid for pH adjustment, an antibacterial drug, a fluorine compound, and an antioxidant are added to the collected urine. When various acids are added to the collected urine to adjust the pH to 4.5 to 6.5, and the collected urine is preserved by adding an antibacterial agent and a predetermined amount of a fluorine compound, C-peptide, albumin, glycine, It is possible to prevent denaturation and increase / decrease of urinary dissolved components such as urea and glucose (see Japanese Patent Application No. 5-5675). Further, in the present invention, since an antioxidant is further added to the collected urine, the concentration of the target component can be accurately detected by using creatinine as a measurement target.

【0005】[0005]

【発明の実施の態様】以下、図面に基づいて、本発明を
更に詳細に説明する。図1は、本発明に係る採尿用キッ
トについて、その構成要素を図示した斜視図であり、図
2は、採尿用キットの使用方法(a)と構成要素の詳細
(b)を説明する図面である。図示の採尿用キットは、
略円筒状に形成された採尿ホルダー1と、採尿時に採取
ホルダー1に挿入される試験管2と、有底円筒形の採尿
コップ3とで構成されており、採尿ホルダー1の先端部
1aには、採尿具4が装着されている。採尿ホルダー1
は、試験管2よりやや大きい内径を有する有底円筒形状
であり、その開口部1bの外周には、操作用フランジ1
cが形成されている。また、ホルダー先端部1aの内周
にはネジ溝が形成されていて、採尿具4をネジ込んで装
着できるようになっている。なお、ホルダー先端部1a
と採尿具4のネジ溝を省略して、ホルダー先端部1aに
採尿具4を嵌合させるようにしても良い。採尿具4は、
軸方向の貫通穴を備える採尿具本体5と、前記貫通穴に
連通して採尿具本体5に固着される注入針6と、注入針
6を被覆する針カバー7とで構成されている。図2
(b)に詳細を示すように、採尿具本体5は、円筒状に
形成された尿接触部5Aと、尿接触部5Aより大径の装
着フランジ5Bと、ホルダー先端部1aの内周に対応し
たネジ溝を有する螺着部5Cと、断面矢印状に形成され
た先細部5Dとで構成されている。ここで、針カバー7
は、弾性材料で形成されているので、注入針6を被覆し
た状態では、針カバーの開口部7aは、採尿具本体5の
先細部5Dに係止される。また、採尿具4を採尿ホルダ
ー1にネジ込んでゆくと、装着フランジ5Bがホルダー
先端部1aに当接されて装着が完了する。なお、尿接触
部5Aの外周には、軸方向に延びる突条5aが設けられ
ているので、採尿具4を、容易かつ確実に採尿ホルダー
1に装着することができる。試験管2は、弾性材料から
なるキャップ2aによって密封されており、内部は所定
の減圧状態に維持されている。また、試験管2の適所に
は指示帯2bが設けられていて、採尿すべき量を明示し
ている。試験管2は、その内部が採尿コップ3からの採
取量に合わせて所定値に減圧されているので、通常、指
示帯2bは不要であるが、指示帯2bが採尿量の目印に
なるので、キャップ2aを誤って開放したような場合に
も所定量の採尿が可能となる。減圧状態の試験管2の中
には、pH調整用の酸と抗菌性薬剤とフッ素化合物と抗
酸化剤とが予め封入されており、この点にも本発明の特
徴がある。pH調整用の酸は、採取尿のpHを4.5〜
6.5に調整するものであり、顆粒状のクエン酸が好適
であるので、例えば、尿1mlあたり4mg程度のクエン酸
を用いることにする。また、抗菌性薬剤として、例え
ば、尿1mlあたり0.4〜4.0mgのEDTA・2Na
を用い、フッ素化合物として、例えば、尿1mlあたり1
mg以上のNaFを用いる。抗酸化剤についても同様であ
り、特に限定されるものではないが、グルタチオンを尿
1mlあたり1〜5mg、または、アスコルビン酸を尿1ml
あたり1〜5mgを添加することにする。
BEST MODE FOR CARRYING OUT THE INVENTION The present invention will now be described in more detail with reference to the drawings. FIG. 1 is a perspective view illustrating components of a urine collecting kit according to the present invention, and FIG. 2 is a diagram illustrating a usage (a) of the urine collecting kit and details (b) of the components. is there. The illustrated urine collection kit
The urine collection holder 1 is formed in a substantially cylindrical shape, the test tube 2 is inserted into the collection holder 1 when collecting urine, and the bottomed cylindrical urine collection cup 3 is provided. The urine collection tool 4 is attached. Urine collection holder 1
Has a bottomed cylindrical shape having an inner diameter slightly larger than that of the test tube 2, and the operation flange 1 is provided on the outer periphery of the opening 1b.
c is formed. In addition, a thread groove is formed on the inner circumference of the holder front end portion 1a so that the urine collecting tool 4 can be screwed in and attached. The tip of the holder 1a
The thread groove of the urine collecting tool 4 may be omitted, and the urine collecting tool 4 may be fitted to the tip portion 1a of the holder. The urine collection tool 4
It is composed of a urine collecting tool body 5 having an axial through hole, an injection needle 6 communicating with the through hole and fixed to the urine collecting tool body 5, and a needle cover 7 covering the injection needle 6. FIG.
As shown in detail in (b), the urine collection device main body 5 corresponds to a cylindrical urine contact portion 5A, a mounting flange 5B having a diameter larger than that of the urine contact portion 5A, and an inner circumference of the holder tip portion 1a. It is composed of a threaded portion 5C having the above-mentioned thread groove and a tapered portion 5D formed in an arrow cross section. Here, the needle cover 7
Is made of an elastic material, so that the opening 7a of the needle cover is locked to the tapered portion 5D of the urine collection device main body 5 when the injection needle 6 is covered. Further, when the urine collecting tool 4 is screwed into the urine collecting holder 1, the mounting flange 5B is brought into contact with the holder tip portion 1a, and the mounting is completed. Since the ridge 5a extending in the axial direction is provided on the outer circumference of the urine contact portion 5A, the urine collection tool 4 can be easily and reliably mounted on the urine collection holder 1. The test tube 2 is sealed by a cap 2a made of an elastic material, and the inside thereof is maintained in a predetermined reduced pressure state. In addition, an indicator band 2b is provided at an appropriate position on the test tube 2 to clearly indicate the amount of urine to be collected. Since the inside of the test tube 2 is depressurized to a predetermined value in accordance with the amount collected from the urine collection cup 3, the indicator band 2b is usually unnecessary, but the indicator band 2b serves as a mark of the urine collection amount. Even if the cap 2a is accidentally opened, a predetermined amount of urine can be collected. An acid for pH adjustment, an antibacterial agent, a fluorine compound, and an antioxidant are previously enclosed in the test tube 2 in a reduced pressure state, and this is also a feature of the present invention. The pH-adjusting acid adjusts the pH of the collected urine to 4.5-
It is adjusted to 6.5, and granular citric acid is suitable. Therefore, for example, about 4 mg of citric acid is used per 1 ml of urine. As an antibacterial agent, for example, 0.4 to 4.0 mg of EDTA.2Na per 1 ml of urine is used.
As a fluorine compound, for example, 1 per 1 ml of urine
Use more than mg NaF. The same applies to anti-oxidants, although not particularly limited, glutathione is 1 to 5 mg per 1 ml of urine, or ascorbic acid is 1 ml of urine.
1 to 5 mg will be added per time.

【0006】続いて、図1や図2に示す採尿用キットの
使用方法について説明する。先ず、被験者の尿を、採尿
コップ3の底から2cm程度まで採取する。次に、試験
管2を採尿ホルダー1に挿入して、試験管2のキャップ
2aが針カバー7に当たる手前で停止させる(図2
(a)参照)。なお、人指し指と中指の間に採尿ホルダ
ー1を挟み、前記2本の指を操作用フランジ1cに係止
させた状態で、試験管2を軽く親指で押せば、上記の作
業を完了させることができる。この状態のまま、採尿具
4の尿接触部5Aを採尿カップ3の尿に浸し、親指で試
験管2を更に押し込む。すると、キャップ2aと針カバ
ー7とが当接された状態で、注入針6が針カバー7とキ
ャップ2aとを押し破ることになる。この動作に応答し
て、尿接触部5Aと試験管2とが連通されるので、試験
管2の減圧状態に対応した所定量の尿が試験管2に採取
されることになる(図3参照)。続いて、試験管2を採
尿ホルダー1から引き抜いた後、試験管2を十分に振
る。なお、試験管のキャップ2aは、弾性材料により形
成されているので、注入針6を引き抜いた後、キャップ
2aの穴から採取尿がこぼれ出ることはない。試験管2
を振ることにより、試験管2の薬剤と採取尿とが混ざる
ことになり、尿中溶存成分の変性や増減などを長期間に
わたって防止することができる(特開平6−21388
5号公報参照)。しかも、試験管2には、グルタチオン
やアスコルビン酸などの抗酸化剤も含まれているので、
試験管2の採取尿が、例え高温下で長時間放置されるよ
うなことがあっても、クレアチニンが変質することはな
く、したがって、クレアチニンを測定対象にして目的成
分濃度を正確に算出することができる。以上、図1〜図
3に則して、本発明の一例を説明したが、採尿用キット
の具体的な構成は図示のものに限定されるものではな
い。例えば、図4や図5のように、採尿ホルダー1の内
周部に、位置決め部材1dを一体的に設けてもよい。こ
の場合には、位置決め部材1dが、試験管2の挿入に対
応して漸次押し広げられるので、採尿ホルダー1の内径
と、試験管キャップ2aの外径の寸法差に係わらず、試
験管2と採尿具4の中心を容易に位置合わせすることが
できる。
Subsequently, a method of using the urine collecting kit shown in FIGS. 1 and 2 will be described. First, the urine of the subject is collected from the bottom of the urine collection cup 3 to about 2 cm. Next, the test tube 2 is inserted into the urine collection holder 1 and stopped before the cap 2a of the test tube 2 hits the needle cover 7 (FIG. 2).
(A)). The work described above can be completed by lightly pressing the test tube 2 with the thumb while the urine collection holder 1 is sandwiched between the index finger and the middle finger, and the two fingers are locked to the operation flange 1c. it can. In this state, the urine contact portion 5A of the urine collecting tool 4 is immersed in the urine of the urine collecting cup 3 and the test tube 2 is further pushed in with the thumb. Then, the injection needle 6 pushes through the needle cover 7 and the cap 2a while the cap 2a and the needle cover 7 are in contact with each other. In response to this operation, the urine contact portion 5A and the test tube 2 are communicated with each other, so that a predetermined amount of urine corresponding to the depressurized state of the test tube 2 is collected in the test tube 2 (see FIG. 3). ). Then, after pulling out the test tube 2 from the urine collection holder 1, the test tube 2 is shaken sufficiently. Since the cap 2a of the test tube is made of an elastic material, the collected urine does not spill out from the hole of the cap 2a after the injection needle 6 is pulled out. Test tube 2
By shaking, the drug in the test tube 2 and the collected urine are mixed, and the denaturation or increase / decrease of the dissolved components in urine can be prevented over a long period of time (JP-A-6-21388).
No. 5). Moreover, since the test tube 2 also contains antioxidants such as glutathione and ascorbic acid,
Even if the collected urine in the test tube 2 is left under high temperature for a long time, the creatinine does not deteriorate. Therefore, the target component concentration should be accurately calculated by using the creatinine as a measurement target. You can An example of the present invention has been described above with reference to FIGS. 1 to 3, but the specific configuration of the urine collection kit is not limited to that shown in the drawings. For example, as shown in FIGS. 4 and 5, the positioning member 1d may be integrally provided on the inner peripheral portion of the urine collection holder 1. In this case, since the positioning member 1d is gradually expanded in correspondence with the insertion of the test tube 2, the positioning tube 1d is not connected to the test tube 2 regardless of the dimensional difference between the inner diameter of the urine collection holder 1 and the outer diameter of the test tube cap 2a. The center of the urine collecting tool 4 can be easily aligned.

【0007】[0007]

【実施例】図6は、保存剤に抗酸化剤を添加した効果を
示す図面であり、試験管2の中に、クエン酸を4mg/ml
、EDTA・2Naを3mg/ml 、NaFを1mg/ml 、
抗酸化剤5mg/ml に封入して尿を採取した後、40℃で
96時間放置した後のクレアチニン濃度を示している。
なお、図7〜図9は、図6と同一の実施例について、コ
ントロール群と加温放置群(図7)、コントロール群と
抗酸化剤添加保存剤群(図8、図9)の比較を示したも
のである。この実施例では、抗酸化剤としてアスコルビ
ン酸やグルタチオンを添加しているが、抗酸化剤を添加
しなかった場合(加温放置群)に比べ、クレアチニン濃
度の低下を抑制する効果が顕著である。なお、抗酸化能
の点では、抗酸化剤の添加量を増す方が有利であるが、
5mg/ml 以上のアスコルビン酸を添加するとクレアチニ
ン濃度が高値を示す影響が認められ、一方、5mg/ml 以
上のグルタチオンを添加するとクレアチニン濃度が低値
を示す影響が認められるので、アスコルビン酸やグルタ
チオンの添加量は、1〜5mg/ml とするのが好ましい。
なお、保存剤の効果により、C−ペプチド、グリシン、
アルブミン、尿素、ぶどう糖などに殆ど変化が認められ
ない。
EXAMPLE FIG. 6 is a drawing showing the effect of adding an antioxidant to a preservative, wherein 4 mg / ml of citric acid was placed in the test tube 2.
, EDTA ・ 2Na 3 mg / ml, NaF 1 mg / ml,
The figure shows the creatinine concentration after urine was collected by enclosing it in an antioxidant of 5 mg / ml and leaving it at 40 ° C. for 96 hours.
7 to 9 show the comparison between the control group and the warming and leaving group (FIG. 7) and the control group and the antioxidant-containing preservative group (FIGS. 8 and 9) for the same example as FIG. It is shown. In this example, ascorbic acid and glutathione were added as antioxidants, but the effect of suppressing the decrease in creatinine concentration is remarkable as compared with the case where no antioxidants were added (warming-treated group). . From the viewpoint of antioxidant ability, it is advantageous to increase the amount of antioxidant added,
When ascorbic acid of 5 mg / ml or more is added, the effect of high creatinine concentration is observed, while when glutathione of 5 mg / ml or more is added, the effect of low creatinine concentration is observed. The addition amount is preferably 1 to 5 mg / ml.
In addition, due to the effect of the preservative, C-peptide, glycine,
Almost no changes were observed in albumin, urea, glucose, etc.

【0008】[0008]

【発明の効果】以上説明したように、請求項1の発明で
は、採取した尿に各種酸を加えてpHを4.5〜6.5
に調整すると共に、抗菌性薬剤とフッ素化合物とを採取
尿に添加しているので、C−ペプチド、アルブミン、グ
リシン、尿素、ぶどう糖などの尿中溶存成分の変性や増
減を長期間にわたって防止することができる。しかも、
本発明では、採取尿に抗酸化剤を更に添加しているの
で、クレアチニンを測定対象にして目的成分濃度を正確
に検出することもできる。また、請求項3の発明では、
pH調整用の酸と抗菌性薬剤とフッ素化合物と抗酸化剤
とが投入された試験管が、採尿量に対応して所定の減圧
状態に維持されているので、採尿時に、注入針によって
試験管キャップを貫通するだけで、所定量の尿を採取す
ることができる。また、採取尿は、その後、尿中溶存成
分の変性や増減を防止しつつ長期間にわたって試験管内
に保存することができる。
As described above, in the invention of claim 1, various acids are added to the collected urine to adjust the pH to 4.5 to 6.5.
Since the antibacterial agent and the fluorine compound are added to the collected urine in addition to the above, it is necessary to prevent denaturation or increase / decrease of dissolved components in urine such as C-peptide, albumin, glycine, urea and glucose over a long period of time. You can Moreover,
In the present invention, since the antioxidant is further added to the collected urine, the concentration of the target component can be accurately detected by using creatinine as a measurement target. In the invention of claim 3,
Since the test tube into which the acid for pH adjustment, the antibacterial agent, the fluorine compound and the antioxidant is put in is maintained in a predetermined depressurized state corresponding to the amount of urine collected, the test tube is injected by the injection needle during urine collection. A predetermined amount of urine can be collected simply by penetrating the cap. Further, the collected urine can be stored in a test tube for a long period of time while preventing the urine dissolved component from being denatured or increased or decreased.

【図面の簡単な説明】[Brief description of drawings]

【図1】本発明に係る採尿用キットの一例を図示したも
のである。
FIG. 1 illustrates an example of a urine collecting kit according to the present invention.

【図2】採尿用キットの使用方法(a)や採尿具本体の
形状を図示したものである。
FIG. 2 is a diagram illustrating a method of using a urine collecting kit (a) and a shape of a urine collecting tool body.

【図3】採尿用キットによる採尿状態を図示したもので
ある。
FIG. 3 is a diagram showing a urine collecting state by a urine collecting kit.

【図4】採尿ホルダーの別の構成例を図示したものであ
る。
FIG. 4 illustrates another example of the configuration of the urine collection holder.

【図5】図4の採尿ホルダーを詳細に図示したものであ
る。
5 shows the urine collection holder of FIG. 4 in more detail.

【図6】保存剤に抗酸化剤を添加した効果を図示したも
のである。
FIG. 6 illustrates the effect of adding an antioxidant to a preservative.

【図7】コントロール群と加温放置群とを比較した図面
である。
FIG. 7 is a diagram comparing a control group and a warming and leaving group.

【図8】コントロール群とアスコルビン酸添加保存剤群
とを比較した図面である。
FIG. 8 is a drawing comparing the control group and the ascorbic acid-added preservative group.

【図9】コントロール群とグルタチオン添加保存剤群と
を比較した図面である。
FIG. 9 is a drawing comparing the control group and the glutathione-added preservative group.

【符号の説明】[Explanation of symbols]

1 採尿ホルダー 1c (操作用)フランジ 2 試験管 2a キャップ 4 採尿具 5 採尿具本体 5A 尿接触部 6 注入針 1 Urine Collection Holder 1c (For Operation) Flange 2 Test Tube 2a Cap 4 Urine Collection Tool 5 Urine Collection Tool Body 5A Urine Contact Part 6 Injection Needle

Claims (4)

【特許請求の範囲】[Claims] 【請求項1】 尿中の溶存成分であるC−ペプチド、ア
ルブミン、グリシン、尿素、ぶどう糖などを分析測定す
るに際して、採取した尿に各種酸を加えてpHを4.5
〜6.5に調整すると共に、抗菌性薬剤とフッ素化合物
と抗酸化剤とを採取尿に添加することを特徴とする採取
尿の保存方法。
1. When analytically measuring C-peptide, albumin, glycine, urea, glucose, etc., which are dissolved components in urine, various acids are added to the collected urine to adjust the pH to 4.5.
A method for preserving collected urine, characterized in that the antibacterial agent, the fluorine compound, and the antioxidant are added to the collected urine while adjusting to ~ 6.5.
【請求項2】 前記抗酸化剤は、尿1mlあたり1〜5mg
のグルタチオン、または尿1mlあたり1〜5mgのアスコ
ルビン酸であることを特徴とする請求項1に記載の採取
尿の保存方法。
2. The antioxidant is 1 to 5 mg per 1 ml of urine.
The method for preserving collected urine according to claim 1, wherein the amount of glutathione is 1 to 5 mg of ascorbic acid per 1 ml of urine.
【請求項3】 基端部にフランジを有する筒状の採尿ホ
ルダーと、弾性体からなるキャップにより密封され、前
記キャップの方から前記採取ホルダーに挿入される試験
管と、前記採尿ホルダーの先端部に装着される採尿具と
を含んだ採尿用キットであって、 前記採尿具は、先端部に筒状の尿接触部を設けた採尿具
本体と、前記尿接触部に連通して前記採尿具本体に固着
される注入針とを備えており、 前記試験管は、pH調整用の酸と、抗菌性薬剤と、フッ
素化合物と、抗酸化剤とが投入された状態で、採尿量に
対応して所定の減圧状態に維持されており、 採尿時に、前記注入針が前記キャップを貫通することに
より、前記尿接触部と前記試験管の内部とが連通するよ
うになっていることを特徴とする採尿用キット。
3. A tubular urine collection holder having a flange at the base end, a test tube sealed by an elastic cap and inserted into the collection holder from the cap, and a tip of the urine collection holder. A urine collecting kit including a urine collecting tool to be attached to the urine collecting tool, wherein the urine collecting tool is a urine collecting tool body provided with a cylindrical urine contact portion at a distal end thereof, and the urine collecting tool communicating with the urine contact portion. The test tube is provided with an injection needle fixed to the main body, and the test tube corresponds to the amount of collected urine in a state in which an acid for pH adjustment, an antibacterial agent, a fluorine compound, and an antioxidant are added. The urine contact part and the inside of the test tube communicate with each other by allowing the injection needle to penetrate the cap during urine collection. Urine collection kit.
【請求項4】 前記抗酸化剤は、尿1mlあたり1〜5mg
のグルタチオン、または尿1mlあたり1〜5mgのアスコ
ルビン酸である請求項3に記載の採尿用キット。
4. The antioxidant is 1 to 5 mg per 1 ml of urine.
The kit for urine collection according to claim 3, which comprises 1 to 5 mg of ascorbic acid per 1 ml of urine.
JP03001396A 1996-01-23 1996-01-23 Method for storing collected urine and kit for collecting urine Expired - Fee Related JP3592822B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP03001396A JP3592822B2 (en) 1996-01-23 1996-01-23 Method for storing collected urine and kit for collecting urine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP03001396A JP3592822B2 (en) 1996-01-23 1996-01-23 Method for storing collected urine and kit for collecting urine

Publications (2)

Publication Number Publication Date
JPH09196909A true JPH09196909A (en) 1997-07-31
JP3592822B2 JP3592822B2 (en) 2004-11-24

Family

ID=12291987

Family Applications (1)

Application Number Title Priority Date Filing Date
JP03001396A Expired - Fee Related JP3592822B2 (en) 1996-01-23 1996-01-23 Method for storing collected urine and kit for collecting urine

Country Status (1)

Country Link
JP (1) JP3592822B2 (en)

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001108581A (en) * 1999-10-04 2001-04-20 Kunimune Kogyosho:Kk Method for sampling and preserving urine specimen and apparatus therefor
WO2002014832A1 (en) * 2000-08-11 2002-02-21 Kunimune Co., Ltd. Method and device for sampling and storing urine specimen
WO2002086453A1 (en) * 2001-04-20 2002-10-31 Sapporo Immuno Diagnostic Laboratory Instrument for use in collecting and recovering liquid secretion in oral cavity
JP2004029028A (en) * 2003-07-11 2004-01-29 Kunimune:Kk Collection/preservation method for urine specimen
JP2004219279A (en) * 2003-01-15 2004-08-05 Kunimune:Kk Sampling/preserving implement for urine specimen
JP2004283681A (en) * 2003-03-20 2004-10-14 Hitachi Plant Eng & Constr Co Ltd Method and apparatus for pooling urinary waste
EP2232263A2 (en) * 2007-12-14 2010-09-29 Cornell University Method of determing excretion of sodium and other analytes
JP2016505825A (en) * 2012-11-30 2016-02-25 レアサイト インコーポレイテッドRareCyte,Inc. Apparatus, system and method for collecting target materials
WO2018117129A1 (en) * 2016-12-19 2018-06-28 株式会社ユカシカド Urine test device and urine test method
WO2018218825A1 (en) * 2017-05-28 2018-12-06 淄博夸克医药技术有限公司 Male urine sampler for urological department
JPWO2018047883A1 (en) * 2016-09-06 2019-07-18 株式会社ユカシカド Healthcare system using spot urine
JP6811507B1 (en) * 2019-07-12 2021-01-13 株式会社Resvo Biopyrin decomposition inhibitor
WO2021010010A1 (en) * 2019-07-12 2021-01-21 株式会社Resvo Agent for prevention of decomposition of biopyrrin
JP2021524578A (en) * 2018-05-22 2021-09-13 シー・アール・バード・インコーポレーテッドC R Bard Incorporated Urine sampling kit and its method

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05105633A (en) * 1991-10-14 1993-04-27 Shimizu Seiyaku Kk Glucose preparation and its production
JPH0594764U (en) * 1992-05-30 1993-12-24 有限会社佐藤化成工業所 Urine collection container
JPH0625759U (en) * 1992-04-20 1994-04-08 アスカビーエフ株式会社 Urine collection container
JPH06213885A (en) * 1993-01-18 1994-08-05 Kyoto Ikagaku Kenkyusho:Kk Method for conserving urine sample while keeping dissolved constituent
WO1995012812A1 (en) * 1993-11-02 1995-05-11 Private Clinic Laboratories, Inc. Method of monitoring patient compliance with medications prescriptions

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05105633A (en) * 1991-10-14 1993-04-27 Shimizu Seiyaku Kk Glucose preparation and its production
JPH0625759U (en) * 1992-04-20 1994-04-08 アスカビーエフ株式会社 Urine collection container
JPH0594764U (en) * 1992-05-30 1993-12-24 有限会社佐藤化成工業所 Urine collection container
JPH06213885A (en) * 1993-01-18 1994-08-05 Kyoto Ikagaku Kenkyusho:Kk Method for conserving urine sample while keeping dissolved constituent
WO1995012812A1 (en) * 1993-11-02 1995-05-11 Private Clinic Laboratories, Inc. Method of monitoring patient compliance with medications prescriptions

Cited By (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001108581A (en) * 1999-10-04 2001-04-20 Kunimune Kogyosho:Kk Method for sampling and preserving urine specimen and apparatus therefor
WO2002014832A1 (en) * 2000-08-11 2002-02-21 Kunimune Co., Ltd. Method and device for sampling and storing urine specimen
JP2002311021A (en) * 2000-08-11 2002-10-23 Kunimune:Kk Instrument for sampling and storing urine specimen
US6776059B2 (en) 2000-08-11 2004-08-17 Noriaki Kunimune Method and device for sampling and storing urine specimen
JP4675027B2 (en) * 2001-04-20 2011-04-20 株式会社札幌イムノ・ダイアグノスティック・ラボラトリー Oral endocrine collection and collection device
WO2002086453A1 (en) * 2001-04-20 2002-10-31 Sapporo Immuno Diagnostic Laboratory Instrument for use in collecting and recovering liquid secretion in oral cavity
JPWO2002086453A1 (en) * 2001-04-20 2004-08-12 株式会社札幌イムノ・ダイアグノスティック・ラボラトリー Oral secretion collection and collection device
CN100403005C (en) * 2001-04-20 2008-07-16 札幌免疫诊断研究所 Instrument for use in collecting and recovering liquid secretion in oral cavity
JP2004219279A (en) * 2003-01-15 2004-08-05 Kunimune:Kk Sampling/preserving implement for urine specimen
JP2004283681A (en) * 2003-03-20 2004-10-14 Hitachi Plant Eng & Constr Co Ltd Method and apparatus for pooling urinary waste
JP2004029028A (en) * 2003-07-11 2004-01-29 Kunimune:Kk Collection/preservation method for urine specimen
EP2232263A4 (en) * 2007-12-14 2013-11-27 Univ Cornell Method of determing excretion of sodium and other analytes
US9128168B2 (en) 2007-12-14 2015-09-08 Cornell University Method of determing excretion of sodium and other analytes
EP2232263A2 (en) * 2007-12-14 2010-09-29 Cornell University Method of determing excretion of sodium and other analytes
JP2016505825A (en) * 2012-11-30 2016-02-25 レアサイト インコーポレイテッドRareCyte,Inc. Apparatus, system and method for collecting target materials
JPWO2018047883A1 (en) * 2016-09-06 2019-07-18 株式会社ユカシカド Healthcare system using spot urine
WO2018117129A1 (en) * 2016-12-19 2018-06-28 株式会社ユカシカド Urine test device and urine test method
JP6355149B1 (en) * 2016-12-19 2018-07-11 株式会社ユカシカド Urine test apparatus and urine test method
CN110114673A (en) * 2016-12-19 2019-08-09 优卡喜公司 Urinate detection device and urine detection method
US11592372B2 (en) 2016-12-19 2023-02-28 Yukashikado Inc. Urine testing apparatus and urine testing method
WO2018218825A1 (en) * 2017-05-28 2018-12-06 淄博夸克医药技术有限公司 Male urine sampler for urological department
JP2021524578A (en) * 2018-05-22 2021-09-13 シー・アール・バード・インコーポレーテッドC R Bard Incorporated Urine sampling kit and its method
JP6811507B1 (en) * 2019-07-12 2021-01-13 株式会社Resvo Biopyrin decomposition inhibitor
WO2021010010A1 (en) * 2019-07-12 2021-01-21 株式会社Resvo Agent for prevention of decomposition of biopyrrin
CN114127231A (en) * 2019-07-12 2022-03-01 锐思沃株式会社 Anti-decomposition agent for bilirubin oxidation metabolites
EP3998325A4 (en) * 2019-07-12 2023-08-23 Resvo Inc. Agent for prevention of decomposition of biopyrrin

Also Published As

Publication number Publication date
JP3592822B2 (en) 2004-11-24

Similar Documents

Publication Publication Date Title
JPH09196909A (en) Preservation of collected urine and urine collecting kit
US4379458A (en) Trocar sleeves having a ball valve
CA2205359A1 (en) Methods for aiding in the diagnosis of alzheimer's disease by measuring amyloid-beta peptide (x->=41) and tau
CA2477089A1 (en) Blood sampling device
WO2004004779A8 (en) Liquid formulations with a high concentration of human growth hormone (hgh) comprising glycine
WO2005102154A3 (en) Blood glucose meter having integral lancet device and test strip storage vial for single handed use and methods for using same
WO2003009798A3 (en) Device, kit and method for generating and transporting wet biological samples
WO2003095974A3 (en) Collection assembly
EP2494922A3 (en) Processing analyte sensor data
WO2004069300A3 (en) Methods and apparatus for hemostasis following arterial catheterization
JPH0638944A (en) Adaptor for blood sampler
US4280505A (en) Fixation ring for transcutaneous gas sensor probe
US5212092A (en) Storage and calibration solution for multiparameter intravascular blood gas sensor device
US20060275890A1 (en) Method of manufacturing a disposable diagnostic meter
Pruszkowska et al. Direct determination of cadmium in coastal seawater by atomic absorption spectrometry with the stabilized temperature platform furnace and Zeeman background correction
US4809698A (en) Transcutaneous blood gas sensor
CA2250485A1 (en) Diagnostic agent for diabetes
Sieracki et al. A temperature independent pH (TIP) buffer for biomedical biophysical applications at low temperatures
WO2020221676A1 (en) Continuous analyte sensor with magnetic activation
Sakai et al. Gaschromatographic determination of butoxyacetic acid after hydrolysis of conjugated metabolites in urine from workers exposed to 2-butoxyethanol
JP2004212174A (en) METHOD OF pH MEASUREMENT, COMPARISON ELECTRODE, AND MULTIPLE ELECTRODE
JP2002156379A5 (en)
JP2681244B2 (en) Analytical method for urinary dissolved components
US6541267B1 (en) Methods for testing oxidative stress
JP2000236874A5 (en)

Legal Events

Date Code Title Description
A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20040123

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20040203

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20040329

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20040427

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20040624

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20040727

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20040826

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080903

Year of fee payment: 4

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080903

Year of fee payment: 4

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090903

Year of fee payment: 5

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090903

Year of fee payment: 5

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100903

Year of fee payment: 6

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110903

Year of fee payment: 7

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120903

Year of fee payment: 8

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120903

Year of fee payment: 8

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130903

Year of fee payment: 9

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees